Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany)

Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Kahnert (München, Germany), P. Alter (Marburg, Germany), T. Welte (Hannover, Germany), R. Huber (München, Germany), J. Behr (München, Germany), F. Biertz (Hannover, Germany), H. Watz (Grosshansdorf, Germany), R. Bals (Homburg, Germany), C. Vogelmeier (Marburg, Germany), R. Jörres (München, Germany). Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach. 1178

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Prediction of exercise capacity using impulse oscillation system in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015

Exercise related desaturation in patients with COPD – Another step towards phenotyping the disease
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


COPD patients with exertional desaturation have a higher risk of rapid lung function decline
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013

The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

Physical activity (PA) levels during recovery from severe acute exacerbations of COPD (AECOPD)
Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease
Year: 2014

The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014


The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016

Fluctuations in airway function: chronic asthma seen as a complex dynamic system
Source: Annual Congress 2006 - Physiological year in review
Year: 2006


Cardio-metabolic profile, function and physical activity in mild-moderate COPD patients
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015

Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations?
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

The influence of hyperinflation on body composition and cytokine profile in patients with COPD
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013

The Evaluation of nutritional status of stable COPD patients and to investigate the effect of nutritional status on perception of dyspnea, exercise capacity, body composition, hospitalisation and life quality
Source: International Congress 2014 – Clinical presentations
Year: 2014

Evaluation of nutritional status, disease severity and anxiety/depression in COPD patients with different exercise capacity
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Correlation between exercise capacity with FVC%, FEV1% and RV% in patients with airways diseases and severe and very severe lung function obstruction
Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2016